Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Shared decision-making should take place, considering their current health status
Standard FDA review takes 10 to 12 months
All descriptions are based on published research and publicly available information from the brand's official website
Based on these principles, regardless of HbA 1c level or the presence of other glucose-lowering agents, all individuals with diabetes and established or subclinical CVD should be prescribed an agent with proven cardiovascular benefit from the GLP-1 RA class or SGLT2i class [5, 6]
Patients covered by government insurance programs, such as Medicare and Medicaid, are not eligible for this offer
US$ 28.44
US$ 24.12
US$ 27.60
US$ 20.13
US$ 22.80
US$ 25.78
